STAT5A and breast cancer: To verify lack of cross-reactivity between the Stat5a and Stat5b polyclonal antibodies developed to the unique C-termini of Stat5a and Stat5b [5], the two proteins were individually immunoprecipitated from SKBR3 breast cancer cell lysates and resolved by gel electrophoresis.